Article
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults.
Alzheimer's research & therapy - 3 Jul 2017
Li Ge, Shofer Jane B, Petrie Eric C, Yu Chang-En, Wilkinson Charles W, Figlewicz Dianne P, Shutes-David Andrew, Zhang Jing, Montine Thomas J, Raskind Murray A, Quinn Joseph F, Galasko Douglas R, Peskind Elaine R
Abstract excerpt
BACKGROUND: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. METHODS: CSF amyloid beta1-42 (Aβ42), phospho-tau-181 (p-tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
